CtrlK

Command Palette

Search for a command to run...

Kaya

NSE: KAYABSE: 539276DIVERSIFIED CONSUMER SERVICESSPECIAL CONSUMER SERVICES
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0

About Kaya

Kaya hair care solutions using scientific dermatological procedures and products. The Company also sells skin and hair care products through Kaya standalone stores, online and third-party outlets. The Company is a public company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. Kaya Limited was formerly incorporated as Kaya Skin Care Limited on March 27, 2003. The Company name was changed from Kaya Skin Care Limited to Kaya Limited in March, 2012. The Company, headquartered in Mumbai, carries on Skin Care Business in India and through its subsidiary in Middle East region. Up to March 31, 2013, the Kaya Business was conducted as subsidiaries of Marico Limited. Following the demerger, of Kaya business from Marico Limited in September, 2013 the Kaya Business has been conducted by the Company and its subsidiaries. Kaya has pioneered into aesthetic dermatology in India and the Middle East. With presence in 26 cities, it has emerged as largest dermatology chain in India, and are also the largest international chain of skincare clinics in Middle East region across the UAE, The Kingdom of Saudi Arabia (KSA) and Oman. The Company business principally comprises the provision of skin care services and products through Kaya Skin Clinics and it operate the brand name of 'Kaya' in India and Middle East by which, 119 clinics were made operational during the year 2014-15. The Clinics offer skin care solutions using scientific dermatological procedures and products. In 2015, Marico Kaya Enterprises Limited (MaKE) was amalgamated with the Company which came into effect from May 13, 2015 through the Scheme of Arrangement. In terms of the said Scheme, e, the Company allotted 1,28,97,100 fully paid up equity shares of face value of Rs 10 /- each on June 1, 2015 to the entitled shareholders of MaKE in the Share Exchange Ratio of 1:1 on May 27, 2015. In 2022-23, the Company through its subsidiary company, viz., Kaya Middle East FZE acquired 100% stake in Kaya Trading LLC (UAE); Kaya Skin Care Clinic LLC (UAE); Kaya Skin Care Clinic - Sole Proprietorship LLC (UAE) and Kaya Beauty Clinic - Sole Proprietorship LLC (UAE). Also, a subsidiary viz., Kaya Skin Medical Centre LLC was incorporated by the step-down subsidiary, viz., Kaya Middle East FZE. In 2024, Company expanded its product range to include Haircare, Nutraceuticals, Bath & Body Solutions, to meet diverse needs of customers. Additionally, it introduced complementary products for services such as post-laser care, body treatments, and comprehensive hair care regimes. The second clinic was launched in Ludhiana in FY25.

Price Action • KAYA

Financial Statements

Consolidated & Standalone Reports

MetricTTMMar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16Mar '15
Total Revenue
230.26234.48214.94182.17149.82129.58212.9214.73210.78205.93197.69190.09
Operating Expenses
212.44192.69292.52205.94127.88100.55169.21208.96211.25213.48196.61168.23
Operating Profit
7.2424.73-82.19-27.6313.0216.5235.130.85-10.06-19.43-11.295.85
Operating Margin (%)
-10.55-38.24-15.178.6912.7516.50.4-4.77-9.44-5.713.08
Total Expenses
-260.99353.66267.65175.29143.7225.78224.24224.5224.17206.31174.63
EBITDA
-41.79-77.58-23.7821.9329.0243.695.77-0.47-7.551.0821.86
EBITDA Margin (%)
-17.82-36.09-13.0514.6422.420.522.69-0.22-3.660.5411.5
Interest Expenses
33.0330.6625.8932.3112.5411.1712.0600.10.0300.01
Depreciation
39.9837.6435.2529.434.8631.9744.515.2713.1410.669.76.39
Profit Before Tax (PBT)
-55.19-26.51-138.72-85.49-25.48-14.12-12.87-9.51-13.71-18.23-8.6215.46
Tax Expenses
00000021.07-5.55-0.38-2.540-0.02
PAT Before Extraordinary Items
--26.51-138.72-85.49-25.48-14.12-33.94-3.96-13.34-15.69-8.6215.48
Net Profit
-55.19-26.51-138.72-85.49-25.48-14.12-33.94-3.96-13.34-15.69-8.6214.78
Net Profit Margin (%)
--12.19-65.95-47.94-18.07-12.06-16.6-1.88-6.62-8.08-4.658.49
EPS (Adjusted)
--17.46-91.34-56.29-16.77-9.3-22.35-2.61-8.78-10.33-5.689.73

Valuation & Key Ratios

Performance Metrics

MetricTTMMar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16Mar '15
Book Value Per Share
--106.47-89.412.1568.9878.0487.99124.71144.34153.63148.47154.6
Return on Assets (ROA) %
--11.19-62.85-28.23-7.89-5.09-11.18-1.52-5.1-5.52-3.095.2
Return on Equity (ROE) %
-00-538.51-28.27-13.85-29.52-2.42-7.09-7.84-4.57.41
Return on Capital Employed (ROCE) %
-4.37-136.52-32.54-5.76-1.59-0.41-5.79-7.22-9.08-4.367.55
Profitability Ratios
------------
Liquidity Ratios
------------
Valuation Ratios
------------
Debt to Equity Ratio
--1.03-1.085.780.870.210.0800000

Featured Insight

No recent news available

Key People

N
Nitika Dalmia
Company Secretary,Compliance Officer
M
Mr. Rajiv Suri
Global Chief Executive Officer
M
Mr. Arihant Dhariwal
Chief Financial Officer
M
Ms. Amrita Chowdhury
Vice President,Head(Human Resources)
M
Mr. Nishant Nayyar
Vice President,Head(Marketing Support)
M
Mr. Lokesh Wagadre
Vice President,Head(Information Technology)
D
Dr. Aparna Santhanam
Head(Medical,Operations)
M
Ms. Jayanti Sati
Associate Vice President(E-Commerce,Product)

Frequently Asked Questions